After grilling an NIH scientist over COVID emails, Congress turns to Anthony Fauci

Former National Institutes of Health official Anthony Fauci has faced many hostile questions from members of Congress, but when he appears before a House panel on Monday, he’ll have something new to answer for: a trove of incendiary emails written by one of his closest advisers.

COVID will still be here this summer: Will anyone care?

Despite “FLiRT” variants, this may be the first COVID wave with little federal pressure to limit transmission or data to even declare a surge.

Novavax awaits FDA decision on whether its next COVID shot can be offered in US

Novavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing that targets a variant that was dominant earlier this year, the company said.

RFK Jr. hits Trump’s COVID-19 response in bid for Libertarian vote

Robert F. Kennedy Jr. attacked former President Donald Trump on his response to the COVID-19 pandemic. “Trump presided over the greatest restriction of individual liberties this country has ever known. He did not stand up for the Constitution when it really mattered,” Kennedy said Friday.

What are the FLiRT COVID variants and are they more contagious?

The so-called FLiRT variants of SARS-CoV-2 coronavirus that cause COVID-19 have been the dominant forms of the virus circulating this year globally, according to the World Health Organization.

4 years on, COVID-19 remains a worse killer than the flu, US study finds

COVID-19 remained a bigger killer than the flu last winter, despite hopes the pandemic virus would eventually blend into the background with other respiratory germs that cause seasonal epidemics, a U.S. study showed.

5 ways North Texans combatting anti-Asian hate in wake of COVID-19

The coronavirus pandemic ushered in a wave of anti-Asian hate, but it also lit a flame in the hearts of many Asian Americans who turned to activism and advocacy in the face of racism.

Moderna says FDA delaying decision on RSV vaccine approval

US regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to “administrative constraints” at the Food and Drug Administration, as the company works to get its second product to market.

A slice of tourists hasn’t returned since COVID. L.A. wants them back.

Los Angeles has rebounded after the dark days of COVID-19 to reassert itself as one of the country’s most popular travel destinations. The recovery, however, is incomplete as visits from international travelers remain well below pre-pandemic levels.

Army veteran Brad Wenstrup leaving Congress. Until then ‘after-action review’ of pandemic will continue

Before he came to Congress, Brad Wenstrup was a podiatrist, a combat surgeon in Iraq, an Army Reserve officer and a candidate for Cincinnati mayor.